Training The Next Generation of Psychedelic Assisted Therapists with Peter Hunt from Mind Medicine Australia
On 1 Feb the Therapeutic Goods Administration (TGA) announced that - from the 1st July 2023 - the medical use of MDMA and Psilocybin will be rescheduled from Schedule 9 (prohibited substances) to Schedule 8 (controlled medicines) of the Poisons Standard. This will enable authorised psychiatrists to prescribe these substances for treatment-resistant depression and treatment resistant post-traumatic stress disorder.
Also available on:
Join talklink as a practitioner
Create your talklink profile and reach the millions of Australians seeking quality mental health services every year.